vs
Axsome Therapeutics, Inc.（AXSM）与RESOURCES CONNECTION, INC.（RGP）财务数据对比。点击上方公司名可切换其他公司
Axsome Therapeutics, Inc.的季度营收约是RESOURCES CONNECTION, INC.的1.7倍（$196.0M vs $117.7M），RESOURCES CONNECTION, INC.净利率更高（-10.8% vs -14.6%，领先3.8%），Axsome Therapeutics, Inc.同比增速更快（65.0% vs -19.2%），RESOURCES CONNECTION, INC.自由现金流更多（$15.6M vs $-18.7M），过去两年Axsome Therapeutics, Inc.的营收复合增速更高（61.7% vs -11.8%）
Jazz Pharmaceuticals是一家全球生物制药企业，专注于肿瘤学与神经科学领域的药物研发及商业化。公司2003年在美国加利福尼亚州成立，目前总部位于爱尔兰都柏林，业务覆盖全球多个核心市场。
RGP原名 Resources Global Professionals，是 Resources Connection, Inc. 的核心运营主体，面向全球客户提供多领域专业咨询服务，覆盖财务会计、信息管理、治理风险合规、人力资本、法务监管、企业咨询与重组、战略传播以及供应链管理等板块。
AXSM vs RGP — 直观对比
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $196.0M | $117.7M |
| 净利润 | $-28.6M | $-12.7M |
| 毛利率 | — | 37.1% |
| 营业利润率 | -13.8% | -10.3% |
| 净利率 | -14.6% | -10.8% |
| 营收同比 | 65.0% | -19.2% |
| 净利润同比 | 61.9% | 81.6% |
| 每股收益（稀释后） | $-0.55 | $-0.38 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $196.0M | $117.7M | ||
| Q3 25 | $171.0M | $120.2M | ||
| Q2 25 | $150.0M | $139.3M | ||
| Q1 25 | $121.5M | $129.4M | ||
| Q4 24 | $118.8M | $145.6M | ||
| Q3 24 | $104.8M | $136.9M | ||
| Q2 24 | $87.2M | $148.2M | ||
| Q1 24 | $75.0M | $151.3M |
| Q4 25 | $-28.6M | $-12.7M | ||
| Q3 25 | $-47.2M | $-2.4M | ||
| Q2 25 | $-48.0M | $-73.3M | ||
| Q1 25 | $-59.4M | $-44.1M | ||
| Q4 24 | $-74.9M | $-68.7M | ||
| Q3 24 | $-64.6M | $-5.7M | ||
| Q2 24 | $-79.3M | $10.5M | ||
| Q1 24 | $-68.4M | $2.5M |
| Q4 25 | — | 37.1% | ||
| Q3 25 | — | 39.5% | ||
| Q2 25 | — | 40.2% | ||
| Q1 25 | — | 35.1% | ||
| Q4 24 | — | 38.5% | ||
| Q3 24 | — | 36.5% | ||
| Q2 24 | — | 40.2% | ||
| Q1 24 | — | 37.0% |
| Q4 25 | -13.8% | -10.3% | ||
| Q3 25 | -27.0% | -1.7% | ||
| Q2 25 | -24.5% | -47.0% | ||
| Q1 25 | -46.9% | -38.4% | ||
| Q4 24 | -61.1% | -52.7% | ||
| Q3 24 | -59.8% | -3.5% | ||
| Q2 24 | -89.5% | 7.6% | ||
| Q1 24 | -89.7% | 2.8% |
| Q4 25 | -14.6% | -10.8% | ||
| Q3 25 | -27.6% | -2.0% | ||
| Q2 25 | -32.0% | -52.6% | ||
| Q1 25 | -48.9% | -34.0% | ||
| Q4 24 | -63.1% | -47.2% | ||
| Q3 24 | -61.7% | -4.2% | ||
| Q2 24 | -91.0% | 7.1% | ||
| Q1 24 | -91.1% | 1.7% |
| Q4 25 | $-0.55 | $-0.38 | ||
| Q3 25 | $-0.94 | $-0.07 | ||
| Q2 25 | $-0.97 | $-2.21 | ||
| Q1 25 | $-1.22 | $-1.34 | ||
| Q4 24 | $-1.54 | $-2.08 | ||
| Q3 24 | $-1.34 | $-0.17 | ||
| Q2 24 | $-1.67 | $0.31 | ||
| Q1 24 | $-1.44 | $0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $322.9M | $89.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $88.3M | $194.6M |
| 总资产 | $689.8M | $289.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $322.9M | $89.8M | ||
| Q3 25 | $325.3M | $77.5M | ||
| Q2 25 | $303.0M | $86.1M | ||
| Q1 25 | $300.9M | $72.5M | ||
| Q4 24 | $315.4M | $78.2M | ||
| Q3 24 | $327.3M | $89.6M | ||
| Q2 24 | $315.7M | $108.9M | ||
| Q1 24 | $331.4M | $113.8M |
| Q4 25 | $88.3M | $194.6M | ||
| Q3 25 | $73.7M | $206.4M | ||
| Q2 25 | $73.1M | $207.1M | ||
| Q1 25 | $53.2M | $277.8M | ||
| Q4 24 | $57.0M | $325.7M | ||
| Q3 24 | $92.9M | $407.2M | ||
| Q2 24 | $102.9M | $418.8M | ||
| Q1 24 | $144.0M | $414.9M |
| Q4 25 | $689.8M | $289.3M | ||
| Q3 25 | $669.3M | $287.2M | ||
| Q2 25 | $639.8M | $304.7M | ||
| Q1 25 | $596.7M | $375.6M | ||
| Q4 24 | $568.5M | $424.9M | ||
| Q3 24 | $561.5M | $512.9M | ||
| Q2 24 | $548.2M | $510.9M | ||
| Q1 24 | $545.7M | $523.2M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-18.7M | $15.9M |
| 自由现金流经营现金流 - 资本支出 | $-18.7M | $15.6M |
| 自由现金流率自由现金流/营收 | -9.6% | 13.2% |
| 资本支出强度资本支出/营收 | 0.0% | 0.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-93.9M | $24.3M |
8季度趋势，按日历期对齐
| Q4 25 | $-18.7M | $15.9M | ||
| Q3 25 | $1.0M | $-7.8M | ||
| Q2 25 | $-32.4M | $16.8M | ||
| Q1 25 | $-43.4M | $659.0K | ||
| Q4 24 | $-26.2M | $1.8M | ||
| Q3 24 | $-18.6M | $-309.0K | ||
| Q2 24 | $-30.1M | $3.2M | ||
| Q1 24 | $-53.5M | $20.5M |
| Q4 25 | $-18.7M | $15.6M | ||
| Q3 25 | $988.0K | $-8.0M | ||
| Q2 25 | $-32.4M | $16.5M | ||
| Q1 25 | $-43.7M | $238.0K | ||
| Q4 24 | $-26.2M | $61.0K | ||
| Q3 24 | $-18.7M | $-575.0K | ||
| Q2 24 | $-30.2M | $3.0M | ||
| Q1 24 | $-53.6M | $20.4M |
| Q4 25 | -9.6% | 13.2% | ||
| Q3 25 | 0.6% | -6.6% | ||
| Q2 25 | -21.6% | 11.8% | ||
| Q1 25 | -36.0% | 0.2% | ||
| Q4 24 | -22.1% | 0.0% | ||
| Q3 24 | -17.9% | -0.4% | ||
| Q2 24 | -34.6% | 2.1% | ||
| Q1 24 | -71.4% | 13.5% |
| Q4 25 | 0.0% | 0.3% | ||
| Q3 25 | 0.0% | 0.1% | ||
| Q2 25 | 0.0% | 0.2% | ||
| Q1 25 | 0.3% | 0.3% | ||
| Q4 24 | 0.0% | 1.2% | ||
| Q3 24 | 0.1% | 0.2% | ||
| Q2 24 | 0.1% | 0.1% | ||
| Q1 24 | 0.1% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.30× | ||
| Q1 24 | — | 8.04× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AXSM
暂无分部数据
RGP
| US | $93.7M | 80% |
| Non Us | $24.0M | 20% |
